Peptide record

TPDB05392

Polybia-MPI Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05392
Polybia-MPI
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF AFP-GFuse Antifungipept CAFPdb i2APP ToxinPred 3.0
standard
No
A 14-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
IDWKKLLDAAKQIL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C78H131N19O20
RNCEGHMFPSTYV
LK
1655.01
9.76
3
2
8
+1
0.65
0.064
153.57
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
5500
3.32
1
Residue Composition
number
2
A
0
R
0
N
2
D
0
C
0
E
1
Q
0
G
0
H
2
I
3
L
3
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 2 C: 0 E: 0 Q: 1 G: 0 H: 0 I: 2 L: 3 K: 3 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
14 reviewed residue count
C78H131N19O20 sequence-only estimate (linear, free termini)
1655.01 sequence-only estimate (linear, free termini)
9.76 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
0.65 sequence-only estimate (linear, free termini)
0.064 sequence-only estimate (linear, free termini)
Free Activity
L Activity
Not Available Activity
Free Activity
Antibacterial Activity
venom, social wasp,Polybia paulista Activity
Evidence Records 20 records
Evidence 1 Activity

Activity

MIC
Antibacterial
5 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Activity against G+ and G- bacteria such as E. coli (MIC 5 uM), S. aureus (MIC 9 uM), and B. cereus (MIC 5 uM), and P. aeruginosa (MIC 5 uM). Have anti-
Evidence 2 Activity

Activity

MIC
Antibacterial
9 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

Activity against G+ and G- bacteria such as E. coli (MIC 5 uM), S. aureus (MIC 9 uM), and B. cereus (MIC 5 uM), and P. aeruginosa (MIC 5 uM). Have anti-biofilm and antifungal
Evidence 3 Activity

Activity

MIC
Antibacterial
5 µM

Target

B. cereus

Source & Reference

dbAMP DRAMP

Other

Activity against G+ and G- bacteria such as E. coli (MIC 5 uM), S. aureus (MIC 9 uM), and B. cereus (MIC 5 uM), and P. aeruginosa (MIC 5 uM). Have anti-biofilm and antifungal activities against C. alb
Evidence 4 Activity

Activity

MIC
Antibacterial
5 µM

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP

Other

bacteria such as E. coli (MIC 5 uM), S. aureus (MIC 9 uM), and B. cereus (MIC 5 uM), and P. aeruginosa (MIC 5 uM). Have anti-biofilm and antifungal activities against C. albicans and C. glabrata ( Wang K
Evidence 5 Activity

Activity

Not Available
Anticancer

Target

Breast Cancer
Not Available
Not Available

Assay & Model

Not Available
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2005

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 6 Activity

Activity

MIC
Antifungal
5 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Activity against G+ and G- bacteria such as E. coli (MIC 5 uM), S. aureus (MIC 9 uM), and B. cereus (MIC 5 uM), and P. aeruginosa (MIC 5 uM). Have anti-
Evidence 7 Activity

Activity

MIC
Antifungal
9 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Activity against G+ and G- bacteria such as E. coli (MIC 5 uM), S. aureus (MIC 9 uM), and B. cereus (MIC 5 uM), and P. aeruginosa (MIC 5 uM). Have anti-biofilm and antifungal
Evidence 8 Activity

Activity

MIC
Antifungal
5 µM

Target

B. cereus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Activity against G+ and G- bacteria such as E. coli (MIC 5 uM), S. aureus (MIC 9 uM), and B. cereus (MIC 5 uM), and P. aeruginosa (MIC 5 uM). Have anti-biofilm and antifungal activities against C. alb
Evidence 9 Activity

Activity

MIC
Antifungal
5 µM

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

bacteria such as E. coli (MIC 5 uM), S. aureus (MIC 9 uM), and B. cereus (MIC 5 uM), and P. aeruginosa (MIC 5 uM). Have anti-biofilm and antifungal activities against C. albicans and C. glabrata ( Wang K
Evidence 10 Activity

Activity

MIC
Antiparasitic
5 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Activity against G+ and G- bacteria such as E. coli (MIC 5 uM), S. aureus (MIC 9 uM), and B. cereus (MIC 5 uM), and P. aeruginosa (MIC 5 uM). Have anti-
Evidence 11 Activity

Activity

MIC
Antiparasitic
9 µM

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

Activity against G+ and G- bacteria such as E. coli (MIC 5 uM), S. aureus (MIC 9 uM), and B. cereus (MIC 5 uM), and P. aeruginosa (MIC 5 uM). Have anti-biofilm and antifungal
Evidence 12 Activity

Activity

MIC
Antiparasitic
5 µM

Target

B. cereus

Source & Reference

DRAMP

Other

Activity against G+ and G- bacteria such as E. coli (MIC 5 uM), S. aureus (MIC 9 uM), and B. cereus (MIC 5 uM), and P. aeruginosa (MIC 5 uM). Have anti-biofilm and antifungal activities against C. alb
Evidence 13 Activity

Activity

MIC
Antiparasitic
5 µM

Target

Pseudomonas aeruginosa

Source & Reference

DRAMP

Other

bacteria such as E. coli (MIC 5 uM), S. aureus (MIC 9 uM), and B. cereus (MIC 5 uM), and P. aeruginosa (MIC 5 uM). Have anti-biofilm and antifungal activities against C. albicans and C. glabrata ( Wang K
Evidence 14 Activity

Activity

Toxicity
Hemolytic Cytotoxic
- | NA | target cell: Rat erythrocytes

Target

Rat erythrocytes

Source & Reference

NA
DBAASP
Structural and functional characterization of two novel peptide toxins isolated from the venom of the social wasp Polybia paulista | Peptides | 2005
Evidence 15 Activity

Activity

62% degranulation
Toxicity
100 µM
Cytotoxic
62% degranulation | 100 | µM | target cell: Rat mast cells

Target

Rat mast cells

Source & Reference

NA
DBAASP
Structural and functional characterization of two novel peptide toxins isolated from the venom of the social wasp Polybia paulista | Peptides | 2005
Evidence 16 Activity

Activity

Toxicity
Hemolytic Cytotoxic
- | NA | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial activity and stability of the D-amino acid substituted derivatives of antimicrobial peptide polybia-MPI. | AMB Express | 2016
Evidence 17 Activity

Activity

3.2% Hemolysis
Toxicity
25 µM
Hemolytic Cytotoxic
3.2% Hemolysis | 25 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial activity and stability of stapled helices of polybia-MP1. | Arch Pharm Res | 2017
Evidence 18 Activity

Activity

<1% Hemolysis
Toxicity
12.5 µM
Hemolytic Cytotoxic
<1% Hemolysis | 12.5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial activity and stability of stapled helices of polybia-MP1. | Arch Pharm Res | 2017
Evidence 19 Activity

Activity

50% Cell death
Toxicity
>60 µM
Cytotoxic
50% Cell death | >60 | µM | target cell: Mouse fibroblasts NIH 3T3

Target

Mouse fibroblasts NIH 3T3

Source & Reference

NA
DBAASP
A novel analog of antimicrobial peptide Polybia-MPI, with thioamide bond substitution, exhibits increased therapeutic efficacy against cancer and diminished toxicity in mice. | Peptides | 2010
Evidence 20 Activity

Activity

% Hemolysis
Toxicity
1 %
Hemolytic
Hemolytic_activity: [Ref.29075946] <1% hemolysis at 12.5µM, 3.2% hemolysis at 25µM against human red blood cells.

Target

erythrocytes

Source & Reference

NA
DRAMP
Arch Pharm Res. 2017 Dec 40(12):1414-1419.